In vitro and in vivo pre-clinical studies in MM models using PROTAC targeting BRD4 and other BET proteins reduced the viability of MM cell lines in a time- and concentration-dependent manner and demonstrated suppressed MYC and Akt/mTOR signaling [274]. The gene discussed is DNER; the disease is Miyoshi myopathy.